SMED Sharps Compliance

Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. It focuses on developing management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators. The company was founded in November 1992 and is headquartered in Houston, TX.

SMED stock data



3 Feb 21
11 Apr 21
30 Jun 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Jun 20 Jun 19 Jun 18 Jun 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Feb 21 John W Dalton Common Stock Sell Dispose S No No 13.945 2,000 27.89K 845,482
9 Feb 21 John W Dalton Common Stock Sell Dispose S No No 13.93 3,000 41.79K 847,482
8 Feb 21 John W Dalton Common Stock Sell Dispose S No No 14.39 100 1.44K 850,482
8 Feb 21 John W Dalton Common Stock Sell Dispose S No No 14.38 4,900 70.46K 850,582
3 Feb 21 John W Dalton Common Stock Sell Dispose S No No 12.65 2,600 32.89K 855,482
3 Feb 21 John W Dalton Common Stock Sell Dispose S No No 12.59 4,600 57.91K 858,082
3 Feb 21 John W Dalton Common Stock Sell Dispose S No No 12.5471 3,500 43.91K 862,682
3 Feb 21 John W Dalton Common Stock Sell Dispose S No No 12.5135 6,500 81.34K 866,182
2 Feb 21 Diana P Diaz Common Stock Sell Dispose S No No 12.63 63,235 798.66K 8,575
2 Feb 21 Diana P Diaz Common Stock Option exercise Aquire M No No 4.3 63,235 271.91K 71,810

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

42.7% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 68 68
Opened positions 11 18 -38.9%
Closed positions 11 10 +10.0%
Increased positions 24 16 +50.0%
Reduced positions 20 24 -16.7%
13F shares
Current Prev Q Change
Total value 89.14M 65.79M +35.5%
Total shares 7.06M 7.02M +0.6%
Total puts 0 14.4K EXIT
Total calls 36.5K 11.2K +225.9%
Total put/call ratio 1.3
Largest owners
Shares Value Change
Wasatch Advisors 934.01K $8.83M +27.6%
BLK Blackrock 788.65K $7.45M +4.1%
Royce & Associates 655.1K $6.19M -11.0%
Vanguard 624.24K $5.9M -2.7%
Granahan Investment Management 611.97K $5.78M +76.5%
Renaissance Technologies 405.95K $3.84M -23.8%
Millrace Asset 395.74K $3.74M +1.9%
Uniplan Investment Counsel 337.82K $3.19M +22.8%
STT State Street 211.64K $2M +39.5%
Geode Capital Management 195.13K $1.84M +9.1%
Largest transactions
Shares Bought/sold Change
G2 Investment Partners Management 0 -445.88K EXIT
Granahan Investment Management 611.97K +265.23K +76.5%
FMR 0 -209.97K EXIT
Wasatch Advisors 934.01K +202.11K +27.6%
EAM Investors 142.45K +142.45K NEW
Renaissance Technologies 405.95K -126.5K -23.8%
WFC Wells Fargo & Co. 129.2K +84.93K +191.8%
Royce & Associates 655.1K -81K -11.0%
Susquehanna International 89.14K +72.91K +449.2%
Uniplan Investment Counsel 337.82K +62.79K +22.8%

Financial report summary

  • We may be unable to manage our growth effectively.
  • If the flu related business of our customers decreases, the revenues generated by our business could decrease.
  • Our quarterly results may fluctuate significantly.
  • Our business is dependent on a small number of customers. To the extent we are not successful in winning additional business mandates from our government and commercial customers or attracting new customers, our results of operations and financial condition would be adversely affected.
  • The loss of our senior executives could affect our ability to manage the business profitability.
  • The recent COVID-19 pandemic could have an adverse effect on our operations, results of operations, cash flows and financial condition
  • Risks associated with our acquisition strategy could adversely affect our operating results.
  • Aggressive pricing by existing competitors and the entrance of new competitors could drive down our profits and slow its growth.
  • The lack of customer long-term volume commitments could adversely affect the Company’s profits and future growth.
  • The Company is subject to extensive and costly federal, state and local laws, and existing or future regulations may restrict the Company’s operations, increase our costs of operations and subject us to additional liability.
  • The inability of the Company to operate its treatment facilities would adversely affect its operations
  • The handling, transportation and disposal or treatment of regulated waste carries with it the risk of personal injury to employees and others.
  • Increases in transportation costs may adversely affect our business and results of operation.
  • Restrictions in our Credit Agreement could adversely affect our business, financial condition, results of operations and value of our securities.
  • An inability to win additional government contracts could have a material adverse effect on our operations and adversely affect our future revenue.
  • As a government contractor, we are subject to extensive government regulation, and our failure to comply with applicable regulations could subject us to penalties that may restrict our ability to conduct our business.
  • The possibility of postal work interruptions and restrictions on shipping through the mail would adversely affect the disposal or treatment element of the Company’s business and have an adverse effect on our operations, results of operations and financial condition.
  • The Company’s stock has experienced, and may continue to experience, low trading volume and price volatility.
  • We are subject to the reporting requirements of federal securities laws, and compliance with such requirements can be expensive and may divert resources from other projects, thus impairing our ability to grow.
  • If we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results accurately or to prevent fraud. An inability to report and file our financial results accurately and timely could harm our reputation and adversely impact the trading price of our common stock.
  • We may be subject to information technology system failures, network disruptions and breaches in data security.
Management Discussion
  • Total revenues for the fiscal year ended June 30, 2020 of $51.1 million increased by $6.8 million, or 15.4%, from the total revenues for the fiscal year ended June 30, 2019 of $44.3 million. The increase in revenue is mainly due to increased billings in the Retail, Home Health Care, Assisted Living, Professional and Pharmaceutical Manufacturer market. The increase in billings is partially offset by current year deferred revenue net of product returns on sales in prior periods. Billings by market are as follows (in thousands):
  • *Represents the net impact of the revenue recognition adjustments to arrive at reported generally accepted accounting principles (“GAAP”) revenue. Customer billings include all invoiced amounts associated with products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales, (ii) recognition of certain revenue associated with product returned for treatment and destruction and (iii) provisions for certain product returns and discounts to customers which are accounted for as reductions in sales in the same period the related sales are recorded. See Note 2 “Summary of Significant Accounting Policies” in “Notes to Consolidated Financial Statements”.
  • (1)The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items.
Content analysis
H.S. junior Avg
New words: category, committed, consideration, modification, Nesquehoning, obligation, property, satisfying, transaction, wwith
Removed: maturity, modified, relationship